eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystic fibrosis |
| Symptom | C0035243|respiratory tract infection |
| Sentences | 4 |
| PubMedID- 25533880 | Among several inhaled beta-lactams, ceftazidime was used with varying success in the prevention and treatment of ventilator-associated pneumonia (vap) and improved clinical outcomes in chronic pseudomonas aeruginosa lower respiratory tract infections (lrtis) in patients with cystic fibrosis (cf) or bronchiectasis. |
| PubMedID- 21939536 | Using sequencing-based methods of identification, we observed that m. chimaera organisms contributed equally to respiratory tract infections in patients with cystic fibrosis when compared with m. avium subsp. |
| PubMedID- 26236492 | The few reported cases of infections resulting from s. multivorum usually occurred in severely comorbid patients (table 1), causing, for instance, necrotizing fasciitis and septic shock in a patient with rheumatoid arthritis treated with long-term intermediate-dose corticosteroids (0.25 mg/kg of prednisone per day for more than 30 years) , sepsis in the setting of bacteraemia in a hemodialyzed patient , chronic respiratory tract infection in patients with cystic fibrosis (where, however, it was not associated with a deterioration of pulmonary function during the follow-up period ) and respiratory infection in a patient with chronic obstructive pulmonary disease . |
| PubMedID- 22785192 | The genus achromobacter currently is comprised of seven species, including achromobacter xylosoxidans, an opportunistic and nosocomial pathogen that displays broad-spectrum antimicrobial resistance and is recognized as causing chronic respiratory tract infection in persons with cystic fibrosis (cf). |
Page: 1